<DOC>
	<DOCNO>NCT00167947</DOCNO>
	<brief_summary>Renal function 12 month assess calculated creatinine clearance .</brief_summary>
	<brief_title>Study Evaluating Sirolimus Kidney Transplant Recipients .</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Age old 18 year . Endstage renal disease , subject schedule kidney transplant . Women childbearing potential must pregnant agree medically acceptable method contraception throughout treatment period 3 month follow discontinuation assign treatment . Other inclusion applies . Evidence active systemic localize major infection . Use investigational drug treatment 4 week prior study entry . Known hypersensitivity SRL derivative , macrolide antibiotic , corticosteroid , basiliximab . Multiple organ transplant ( i.e. , prior concurrent transplantation organs renal transplant ) . Immunosuppression therapy allow protocol . Treatment voriconazole , terfenadine , cisapride , astemizole , pimozide , ketoconazole ( know interact SRL ) discontinue prior study entry . Other exclusion applies .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Kidney</keyword>
	<keyword>Transplant</keyword>
</DOC>